DESIGNATED BY THE EGYPTIAN ECONOMIC COURT TO LEAD THE FINANCIAL RESTRUCTURING PROCESS OF THE 19011 PHARMACIES CHAIN, INCLUDING THE ASSESSMENT OF OPERATIONAL, FINANCIAL, AND ADMINISTRATIVE CHALLENGES, AND THE PREPARATION OF A COMPREHENSIVE RESTRUCTURING PLAN TO RESTORE THE COMPANY’S SOLVENCY AND IMPROVE LONG-TERM SUSTAINABILITY.